175 related articles for article (PubMed ID: 38306142)
21. The long and winding road of faecal microbiota transplants to targeted intervention for improvement of immune checkpoint inhibition therapy.
Verhoef JI; Klont E; van Overveld FJ; Rijkers GT
Expert Rev Anticancer Ther; 2023; 23(11):1179-1191. PubMed ID: 37746903
[TBL] [Abstract][Full Text] [Related]
22. Role of gut microbiota in regulating immune checkpoint inhibitor therapy for glioblastoma.
Zhang H; Hong Y; Wu T; Ben E; Li S; Hu L; Xie T
Front Immunol; 2024; 15():1401967. PubMed ID: 38915399
[TBL] [Abstract][Full Text] [Related]
23. Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis.
Jacob V; Crawford C; Cohen-Mekelburg S; Viladomiu M; Putzel GG; Schneider Y; Chabouni F; OʼNeil S; Bosworth B; Woo V; Ajami NJ; Petrosino JF; Gerardin Y; Kassam Z; Smith M; Iliev ID; Sonnenberg GF; Artis D; Scherl E; Longman RS
Inflamm Bowel Dis; 2017 Jun; 23(6):903-911. PubMed ID: 28445246
[TBL] [Abstract][Full Text] [Related]
24. Gut microbiota and immunotherapy of renal cell carcinoma.
Bibbò S; Porcari S; Del Vecchio LE; Severino A; Mullish BH; Ianiro G; Gasbarrini A; Cammarota G
Hum Vaccin Immunother; 2023 Dec; 19(3):2268982. PubMed ID: 37955340
[TBL] [Abstract][Full Text] [Related]
25. Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial.
Costello SP; Hughes PA; Waters O; Bryant RV; Vincent AD; Blatchford P; Katsikeros R; Makanyanga J; Campaniello MA; Mavrangelos C; Rosewarne CP; Bickley C; Peters C; Schoeman MN; Conlon MA; Roberts-Thomson IC; Andrews JM
JAMA; 2019 Jan; 321(2):156-164. PubMed ID: 30644982
[TBL] [Abstract][Full Text] [Related]
26. Antitumor effects of fecal microbiota transplantation: Implications for microbiome modulation in cancer treatment.
Xu H; Cao C; Ren Y; Weng S; Liu L; Guo C; Wang L; Han X; Ren J; Liu Z
Front Immunol; 2022; 13():949490. PubMed ID: 36177041
[TBL] [Abstract][Full Text] [Related]
27. First-in-class Microbial Ecosystem Therapeutic 4 (MET4) in combination with immune checkpoint inhibitors in patients with advanced solid tumors (MET4-IO trial).
Spreafico A; Heirali AA; Araujo DV; Tan TJ; Oliva M; Schneeberger PHH; Chen B; Wong MK; Stayner LA; Hansen AR; Saibil SD; Wang BX; Cochrane K; Sherriff K; Allen-Vercoe E; Xu W; Siu LL; Coburn B
Ann Oncol; 2023 Jun; 34(6):520-530. PubMed ID: 36863483
[TBL] [Abstract][Full Text] [Related]
28. Implication of the Gut Microbiome and Microbial-Derived Metabolites in Immune-Related Adverse Events: Emergence of Novel Biomarkers for Cancer Immunotherapy.
Dora D; Bokhari SMZ; Aloss K; Takacs P; Desnoix JZ; Szklenárik G; Hurley PD; Lohinai Z
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769093
[TBL] [Abstract][Full Text] [Related]
29. The effect of gastrointestinal microbiome supplementation on immune checkpoint inhibitor immunotherapy: a systematic review.
Bhatt A; Haslam A; Prasad V
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7355-7362. PubMed ID: 36928160
[TBL] [Abstract][Full Text] [Related]
30. Immune checkpoint inhibitor gastritis is often associated with concomitant enterocolitis, which impacts the clinical course.
Haryal A; Townsend MJ; Baskaran V; Srivoleti P; Giobbie-Hurder A; Sack JS; Isidro RA; LeBoeuf NR; Buchbinder EI; Hodi FS; Grover S
Cancer; 2023 Feb; 129(3):367-375. PubMed ID: 36377339
[TBL] [Abstract][Full Text] [Related]
31. Targeting the Gut Microbiome to Mitigate Immunotherapy-Induced Colitis in Cancer.
Chang AE; Golob JL; Schmidt TM; Peltier DC; Lao CD; Tewari M
Trends Cancer; 2021 Jul; 7(7):583-593. PubMed ID: 33741313
[TBL] [Abstract][Full Text] [Related]
32. Gut microbiota shed new light on the management of immune-related adverse events.
Tan B; Liu YX; Tang H; Chen D; Xu Y; Chen MJ; Li Y; Wang MZ; Qian JM
Thorac Cancer; 2022 Oct; 13(19):2681-2691. PubMed ID: 36043345
[TBL] [Abstract][Full Text] [Related]
33. Systematic Review and Meta-analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative Colitis.
Narula N; Kassam Z; Yuan Y; Colombel JF; Ponsioen C; Reinisch W; Moayyedi P
Inflamm Bowel Dis; 2017 Oct; 23(10):1702-1709. PubMed ID: 28906291
[TBL] [Abstract][Full Text] [Related]
34. Gut Microbiota and Immune Checkpoint Inhibitors-Based Immunotherapy.
Tian M; Zhang S; Tseng Y; Shen X; Dong L; Xue R
Anticancer Agents Med Chem; 2022; 22(7):1244-1256. PubMed ID: 34229597
[TBL] [Abstract][Full Text] [Related]
35. Protocol for faecal microbiota transplantation in ulcerative colitis (FMTUC): a randomised feasibility study.
Jitsumura M; Cunningham AL; Hitchings MD; Islam S; Davies AP; Row PE; Riddell AD; Kinross J; Wilkinson TS; Jenkins GJ; Williams JG; Harris DA
BMJ Open; 2018 Oct; 8(10):e021987. PubMed ID: 30341117
[TBL] [Abstract][Full Text] [Related]
36. Association of Antibiotic Exposure With Survival and Toxicity in Patients With Melanoma Receiving Immunotherapy.
Mohiuddin JJ; Chu B; Facciabene A; Poirier K; Wang X; Doucette A; Zheng C; Xu W; Anstadt EJ; Amaravadi RK; Karakousis GC; Mitchell TC; Huang AC; Shabason JE; Lin A; Swisher-McClure S; Maity A; Schuchter LM; Lukens JN
J Natl Cancer Inst; 2021 Feb; 113(2):162-170. PubMed ID: 32294209
[TBL] [Abstract][Full Text] [Related]
37. Safety, Clinical Response, and Microbiome Findings Following Fecal Microbiota Transplant in Children With Inflammatory Bowel Disease.
Goyal A; Yeh A; Bush BR; Firek BA; Siebold LM; Rogers MB; Kufen AD; Morowitz MJ
Inflamm Bowel Dis; 2018 Jan; 24(2):410-421. PubMed ID: 29361092
[TBL] [Abstract][Full Text] [Related]
38. Fecal Microbiota Transplantation for Ulcerative Colitis: A Systematic Review and Meta-Analysis.
Shi Y; Dong Y; Huang W; Zhu D; Mao H; Su P
PLoS One; 2016; 11(6):e0157259. PubMed ID: 27295210
[TBL] [Abstract][Full Text] [Related]
39. The Role of Fecal Microbiota Transplantation in the Induction of Remission in Ulcerative Colitis.
Saleh A; Parsa S; Garza M; Quigley EMM; Abraham BP
Dig Dis; 2023; 41(4):656-665. PubMed ID: 36858036
[TBL] [Abstract][Full Text] [Related]
40. Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis.
Paramsothy S; Nielsen S; Kamm MA; Deshpande NP; Faith JJ; Clemente JC; Paramsothy R; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Lin E; Borody TJ; Wilkins MR; Colombel JF; Mitchell HM; Kaakoush NO
Gastroenterology; 2019 Apr; 156(5):1440-1454.e2. PubMed ID: 30529583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
